Many medical professionals throughout history have relied upon the color of blood to determine certain health characteristics of the patient. In a recent Royal Society of Chemistry study, researchers sought to utilize Raman spectroscopy to gain insight into the optical properties of blood samples at the cellular level.
Metropolis Healthcare buys Hitech Diagnostic for Rs 511 cr
Mumbai-based diagnostic services provider Metropolis Healthcare today announced that it has agreed to buy Chennai-based Hitech Diagnostic Center for a cash consideration of Rs 511 cr. Hitech promoters will invest in Metropolis as part of the deal.
Metropolis did not specify the price at which it would allot the 4.95 lakh shares that it will issue as part of the deal, but said it would be done as per Section 164 of SEBI (Issue of Capital and Disclosure Requirements) Regulations.
Assuming that the shares would be issued at around the current market price of Rs 2,167 each, that would mean around Rs 107 cr out of the Rs 511 cr paid to the promoters of Hitech would come back Metropolis in the form of an investment.